Sabra Health Care REIT, Inc.SBRANASDAQ
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +11.60% | +10.07% | +7.39% | +6.76% | +16.21% |
| Gross Profit Growth | +7.92% | +9.63% | +5.49% | +0.74% | +7.33% |
| EBITDA Growth | +41.52% | +13.55% | +43.78% | -1.32% | -13.75% |
| Operating Income Growth | +23.88% | +16.29% | +7.44% | -7.49% | -4.03% |
| Net Income Growth | +172.18% | +53.52% | +173.38% | -24.34% | -41.70% |
| EPS Growth | +169.54% | +54.55% | +180.00% | -27.69% | -45.00% |
| EPS Diluted Growth | +158.15% | +54.55% | +170.00% | -28.92% | -42.11% |
| Weighted Average Shares Growth | +2.32% | +2.78% | +2.74% | +2.39% | +5.40% |
| Weighted Average Shares Diluted Growth | +2.76% | +2.97% | +3.07% | +2.75% | +5.48% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +1.56% | +52.03% | +1.04% | +2.37% | +9.33% |
| Free Cash Flow Growth | +1.56% | +52.03% | +1.04% | +2.37% | +9.33% |
| Receivables Growth | -73.47% | -14.83% | +6.08% | -6.78% | -15.53% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | -1.53% | -2.63% | -0.43% | +3.70% | +3.58% |
| Book Value per Share Growth | -4.41% | -4.99% | -4.45% | +0.51% | -2.34% |
| Debt Growth | -0.09% | -3.03% | +1.10% | +4.61% | +4.33% |
| R&D Expense Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| SG&A Expenses Growth | -21.87% | +7.05% | -1.78% | +1.26% | +22.07% |